Shares in Insulet (NSDQ:PODD) are steady in after-hours trading after the diabetes-focused device maker posted first quarter earnings that topped Wall Street expectations.
The Acton, Mass.-based company posted profits of approximately $4.4 million, or 7¢ per share, on sales of approximately $159.6 million for the three months ended March 31, seeing a swing from the red on the bottom line while sales grew 29.1% when compared with the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business News